Most weight-loss jabs users are at risk of putting the pounds back on because they quit within a year, a new study has found.

Microdosing weight loss drugs, a growing global trend, could offer a new gateway solution for obesity for those priced out of ...

Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But with list prices of roughly $1,000 a month, public and private payers are ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

“Ozempic vagina” is not a medical term, but it’s a phrase trending online to describe body changes after GLP-1 weight loss.

Now, it’s worth noting Stock Advisor’s total average return is 1,066% — a market-crushing outperformance compared to 186 % ...

Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

In March, he revealed he had since switched to Mounjaro, a weight-loss injection recently approved by the NHS, which he said ...

After struggling to find relief, GLP-1s were the "miracle solution" to their PCOS symptoms. But without insurance coverage, many can't afford them.